Insider Trading: ResMed Inc (RMD)
RMD on New York Consolidated
47.99USD
19 Jun 2013
47.99USD
19 Jun 2013
Price Change (% chg)
$0.32 (+0.68%)
$0.32 (+0.68%)
Prev Close
$47.66
$47.66
Open
$47.67
$47.67
Day's High
$48.31
$48.31
Day's Low
$47.51
$47.51
Volume
264,148
264,148
Avg. Vol
1,026,768
1,026,768
52-wk High
$51.40
$51.40
52-wk Low
$29.82
$29.82
| DOUGLAS ROBERT ANDREW | Options Exercised: 0 | ||
| Trade Date: | Thursday, 2 Aug 2012 | Price: | 35.00 |
| Title: | Chief Operating Officer | Shares Held: | 58,224 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 55.30% |
| # of Holders: | 386 |
| Total Shares Held: | 78,779,340 |
| 3 Mo. Net Change: | 1,572,188 |
| # New Positions: | 35 |
| # Closed Positions: | 35 |
| # Increased Positions: | 182 |
| # Reduced Positions: | 164 |
| # Net Buyers: | 18 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Peter Farrell |
70 | 2014 | Non-Executive Chairman of the Board |
Robert Douglas |
53 | 2013 | President, Chief Operating Officer |
Michael Farrell |
40 | 2013 | Chief Executive Officer, Director |
Brett Sandercock |
45 | 2006 | Chief Financial Officer |
Don Darkin |
59 | 2011 | President - Sleep-disordered Breathing Strategic Business Unit |
Jim Hollingshead |
49 | 2013 | President - Americas |
Anne Reiser |
51 | 2012 | President, Europe |
David Pendarvis |
53 | 2011 | Chief Administrative Officer, Global General Counsel, Company Secretary |
Gary Pace |
2010 | Lead Independent Director | |
Michael Quinn |
65 | 1992 | Independent Director |
Christopher Roberts |
58 | 2003 | Independent Director |
Richard Sulpizio |
61 | 2005 | Independent Director |
Ronald Taylor |
65 | 2005 | Independent Director |
John Wareham |
71 | 2005 | Independent Director |

